Find where to buy products from suppliers in the USA, including: distributors, industrial manufacturers in America, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the American suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the UK.
| Product | Description | |
|---|---|---|
| Eptifibatide | An arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events. Uses: Platelet aggregation inhibitors. Synonyms: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide; Eftifibatide; Integrelin; Integrilin; Intrifiban; Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Cys bridge); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide; deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7). Grade: 98%. CAS No. 188627-80-7. Molecular formula: C35H49N11O9S2. Mole weight: 831.97. |  |
| Eptifibatide | Eptifibatide. Categories: eptifibatide; 188627-80-7. |  CA, FL & NJ |
| Eptifibatide | Eptifibatide. Group: Biochemicals. Grades: Purified. CAS No. 188627-80-7. Pack Sizes: 1mg. US Biological Life Sciences. |  Worldwide |
| Eptifibatide | Eptifibatide is a cyclic heptapeptide, acts as a competitive antagonist for the activated platelet glycoprotein IIb/IIIa receptor , with anti-platelet activity [1]. Uses: Scientific research. Group: Peptides. CAS No. 188627-80-7. Pack Sizes: 5 mg; 10 mg; 25 mg; 50 mg; 100 mg. Product ID: HY-B0686. |  |
| Eptifibatide acetate | Eptifibatide acetate, an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class, is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue. It reversibly binds to platelets to reduce the risk of cardiac ischemic events. Synonyms: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide, acetate (1:x); deamino-Cys(1)-hArg-Gly-Asp-Trp-Pro-Cys(1)-NH2.xCH3CO2H; Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide acetate salt; Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2 (Mpr&Cys bridge) acetate. Grade: ≥95%. CAS No. 881997-86-0. Molecular formula: C35H49N11O9S2.xC2H4O2. Mole weight: 831.97 (free base). | |
| Eptifibatide Acetate | ?98% (HPLC). Group: Fluorescence/luminescence spectroscopyapi standardspharmaceutical toxicology. Alternative Names: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-?-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1?6)-disulfide, acetate (9CI), Eptifibatide acetate,L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-?-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1?6)-disulfide, acetate (1:?). |  |
| Eptifibatide Dimer (Antiparallel) | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Cys,Cys&Mpr bridge); Mpr-Har-GDWPC-NH2(Mpr&Cys,Cys&Mpr bridge); Eptifibatide (Dimer, unparallel); deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2.deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7', Cys7-Cys1'); L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→6'),(6→1')-bis(disulfide); Eptifibatide Dimer; N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6'),(6-1')-bis(disulfide); Eptifibatide Impurity 3. Grade: ≥95%. CAS No. 1505450-99-6. Molecular formula: C70H98N22O18S4. Mole weight: 1663.93. | |
| Eptifibatide Dimer (parallel) | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Mpr,Cys&Cys bridge); Mpr-Har-GDWPC-NH2(Mpr&Mpr,Cys&Cys bridge); Eptifibatide Dimer(parallel); deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2.deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys1', Cys7-Cys7'); L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, bimol. cyclic (1→1'),(6→6')-bis(disulfide); Eptifibatide Dimer; N6-Amidino-N2-(3-mercaptopropionyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-Lprolyl-L-cysteinamide, cyclic(1-1'),(6-6')-bis(disulfide). Grade: ≥95%. CAS No. 1505451-00-2. Molecular formula: C70H98N22O18S4. Mole weight: 1663.93. | |
| Eptifibatide Impurity 1 | Eptifibatide Impurity 1 is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Molecular formula: C35H48N10O10S2. Mole weight: 832.95. | |
| Eptifibatide Impurity 2 | Eptifibatide Impurity 2 is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Molecular formula: C35H51N11O10S2. Mole weight: 849.98. | |
| Eptifibatide Impurity 3 | Eptifibatide Impurity 3 is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Molecular formula: C70H98N22O18S4. Mole weight: 1663.93. | |
| Eptifibatide monoacetate | Eptifibatide monoacetate, an antiplatelet drug of the glycoprotein IIb/IIIa inhibitor class, is a cyclic heptapeptide constructed from 6 amino acids and a mercaptopropionyl residue. It reversibly binds to platelets to reduce the risk of cardiac ischemic events. Synonyms: L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide, acetate (1:1); deamino-Cys(1)-hArg-Gly-Asp-Trp-Pro-Cys(1)-NH2.CH3CO2H; Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide acetic acid; Eptifibatide acetate; Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2 (Mpr&Cys bridge) acetate. Grade: ≥95%. CAS No. 1248559-53-6. Molecular formula: C35H49N11O9S2.C2H4O2. Mole weight: 892.02. | |
| Eptifibatide Trisulfide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr&Cys Trisulfidebridge); Mpr-Har-GDWPC-NH2(Mpr&Cys Trisulfidebridge); deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Trisulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-trisulfide; Trisulphide Eptifibatide. Grade: ≥95%. Molecular formula: C35H49N11O9S3. Mole weight: 864.03. | |
| Additional homo Arg, Eptifibatide impurity | Additional homo Arg, Eptifibatide impurity is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Synonyms: Mpr-(Homo-Arg)-(Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bond Mpr1/Cys8); Mpr-hArg-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bond Mpr1/Cys8); Mpr(1)-hArg-hArg-Gly-Asp-Trp-Pro-Cys(1)-NH2. Molecular formula: C42H63N15O11S2. Mole weight: 1018.18. | |
| Asp-Clipped Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: A?Mpr-Har-Gly-Asp B?Trp-Pro-Cys-NH2(Mpr1&Cys7 bridge); A:Mpr-Har-GD B?WPC-NH2(Mpr&Cys bridge); L-Aspartic acid, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-, (1→3')-disulfide with L-tryptophyl-L-prolyl-L-cysteinamide; Trp-Pro-Cys(1)-NH2, Cys(1)-deamino-hArg-Gly-Asp(Disulfide bond); deamino-Cys-hArg-Gly-Asp.Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys3'); Eptifibatide Impurity 2. Grade: ≥95%. CAS No. 358620-99-2. Molecular formula: C35H51N11O10S2. Mole weight: 849.98. | |
| D-Asp4-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-DAsp-Trp-Pro-Cys-NH2(Mpr1&Cys7 bridge); Mpr-Har-G-DAsp-WPC-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-D-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-D-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide; [D-Asp]4-Eptifibatide; [D-Asp4]-Eptifibatide; D-Asp(4)-Eptifibatide; 4-D-Asp-Eptifibatide; L-Cysteinamide, N-(3-mercapto-1-oxopropyl)-6-[(aminoiminomethyl)amino]-L-norleucylglycyl-D-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-thioether. Grade: ≥95%. CAS No. 3079028-51-3. Molecular formula: C35H49N11O9S2. Mole weight: 831.97. | |
| D-Cys7-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-DCys-NH2(Mpr1&Cys7 bridge); Mpr-Har-GDWP-DCys-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-Asp-Trp-Pro-D-Cys-NH2 (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-D-cysteinamide (1->7)-disulfide; D-Cys7 Eptifibatide; 7-D-Cys Eptifibatide; [D-Cys]7-Eptifibatide; [D-Cys7]-Eptifibatide; D-Cys(7)-Eptifibatide; (D-Cys)7 Eptifibatide impurity. Grade: ≥95%. Molecular formula: C35H49N11O9S2. Mole weight: 831.97. | |
| (D-Cys)7 Eptifibatide impurity | (D-Cys)7 Eptifibatide impurity is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Synonyms: Mpr-(Homo-Arg)-Gly-Asp-Trp-Pro-(D-Cys)-NH2 (Disulfide bond Mpr1/Cys7); Mpr-hArg-Gly-Asp-Trp-Pro-D-Cys-NH2 (Disulfide bond Mpr1/Cys7). Molecular formula: C35H49N11O9S2. Mole weight: 831.97. | |
| Deamidated Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Cys(Mpr1&Cys7 bridge); Mpr-Har-GDWPC(Mpr&Cys bridge); Eptifibatide Impurity 1; deamino-Cys-hArg-Gly-Asp-Trp-Pro-Cys-OH (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteine (1->7)-disulfide; L-Cysteine, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-disulfide; Deamidated Eptifibatide Impurity; Eptifibatide Acid; [Cys-OH]7-Eptifibatide; [Cys7]-Eptifibatide; Cys7-OH-Eptifibatide. Grade: ≥95%. CAS No. 618118-95-9. Molecular formula: C35H48N10O10S2. Mole weight: 832.95. | |
| Des-Gly3-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Asp-Trp-Pro-Cys-NH2(Mpr&Cys bridge); Mpr-Har-DWPC-NH2(Mpr&Cys bridge); Des-Gly Eptifibatide; Eptifibatide impurity Y; [Des-Gly]3-Eptifibatide; [Des-Gly3]-Eptifibatide; Des-Gly(3)-Eptifibatide; deamino-Cys-hArg-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys6); Deamino-cysteinyl-L-homoarginyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->6)-disulfide. Grade: ≥95%. Molecular formula: C33H46N10O8S2. Mole weight: 774.91. | |
| Des-Mpr-Harg Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Gly-Asp-Trp-Pro-Cys-NH2; Eptifibatide (3-7); GDWPC-NH2; Glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide; Des-Mpr-hArg-Eptifibatide; Eptifibatide fragment 3-7. Grade: ≥95%. Molecular formula: C25H33N7O7S. Mole weight: 575.64. | |
| Des-Pro6-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Cys-NH2(Mpr1&Cys6 bridge); Mpr-Har-GDWC-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-Asp-Trp-Cys-NH2 (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-cysteinamide (1->7)-disulfide; [Des-Pro]6-Eptifibatide; [Des-Pro6]-Eptifibatide; Des-Pro(6)-Eptifibatide. Grade: ≥95%. Molecular formula: C30H42N10O8S2. Mole weight: 734.85. | |
| Des-Trp5-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Pro-Cys-NH2(Mpr1&Cys6 bridge); Mpr-Har-GDPC-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-Asp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-prolyl-L-cysteinamide (1->7)-disulfide; [Des-Trp]5-Eptifibatide; [Des-Trp5]-Eptifibatide; Des-Trp(5)-Eptifibatide. Grade: ≥95%. Molecular formula: C24H39N9O8S2. Mole weight: 645.75. | |
| D-Har2-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-DHar-Gly-Asp-Trp-Pro-Cys-NH2(Mpr1&Cys7 bridge); Mpr-DHar-GDWPC-NH2(Mpr&Cys bridge); (D-Homo-Arg)2 Eptifibatide impurity; Mpr-(D-Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bond Mpr1/Cys7); Mpr(D-Homo-Arg)GDWPC-NH2 (Disulfide bond Mpr1/Cys7); deamino-Cys-D-hArg-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-D-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide; Eptifibatide Impurity 4; D-Har Eptifibatide; N6-Amidino-N2-(3-mercaptopropionyl)-D-lysylglycyl-D-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide, cyclic(1-6)-disulfide; (D-Homo-Arg)2 Eptifibatide; D-hArg2-Eptifibatide; [D-hArg]2-Eptifibatide; [D-Har2]-Eptifibatide; L-Cysteinamide, N-(3-mercapto-1-oxopropyl)-6-[(aminoiminomethyl)amino]-D-norleucylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→6)-thioether. Grade: ≥95%. CAS No. 3079028-40-0. Molecular formula: C35H49N11O9S2. Mole weight: 831.97. | |
| (D-Homo-Arg)2 Eptifibatide impurity | (D-Homo-Arg)2 Eptifibatide impurity. Synonyms: Mpr-(D-Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bond Mpr1/Cys7). Molecular formula: C28H33O7S2N7. Mole weight: 643.70. | |
| Di-Pro6-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Pro-Pro-Cys-NH2(Mpr1&Cys8 bridge); Mpr-Har-GDWPPC-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-Asp-Trp-Pro-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys8); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-prolyl-L-cysteinamide (1->8)-disulfide; [Di-Pro]6-Eptifibatide; [Di-Pro6]-Eptifibatide; Di-Pro(6)-Eptifibatide. Grade: ≥95%. Molecular formula: C40H56N12O10S2. Mole weight: 929.08. | |
| Di-Trp5-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-Trp-Pro-Cys-NH2(Mpr1&Cys8 bridge); Mpr-Har-GDWWPC-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-Asp-Trp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys8); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->8)-disulfide; [Di-Trp]5-Eptifibatide; [Di-Trp5]-Eptifibatide; Di-Trp(5)-Eptifibatide. Grade: ≥95%. Molecular formula: C46H59N13O10S2. Mole weight: 1018.18. | |
| D-Pro6-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-Trp-DPro-Cys-NH2(Mpr1&Cys7 bridge); Mpr-Har-GDW-DPro-C-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-Asp-Trp-D-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-L-tryptophyl-D-prolyl-L-cysteinamide (1->7)-disulfide; [D-Pro]6-Eptifibatide; [D-Pro6]-Eptifibatide; D-Pro(6)-Eptifibatide; 6-D-Pro-Eptifibatide. Grade: ≥95%. Molecular formula: C35H49N11O9S2. Mole weight: 831.97. | |
| D-Trp5-Eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Asp-DTrp-Pro-Cys-NH2(Mpr1&Cys7 bridge); Mpr-Har-GD-DTrp-PC-NH2(Mpr&Cys bridge); deamino-Cys-hArg-Gly-Asp-D-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys7); Deamino-cysteinyl-L-homoarginyl-glycyl-L-alpha-aspartyl-D-tryptophyl-L-prolyl-L-cysteinamide (1->7)-disulfide; D-Trp(5) Eptifibatide; [D-Trp]5-Eptifibatide; [D-Trp5]-Eptifibatide; 5-D-Trp Eptifibatide. Grade: ≥95%. Molecular formula: C35H49N11O9S2. Mole weight: 831.97. | |
| Gly double addition eptifibatide | An impurity of Eptifibatide. Eptifibatide is a glycoprotein IIb/IIIa inhibitor used primarily to prevent blood clots in patients with acute coronary syndromes (ACS) and during percutaneous coronary interventions (PCI). Synonyms: Mpr-Har-Gly-Gly-Asp-Trp-Pro-Cys-NH2(Mpr1&Cys8 bridge); Mpr-Har-GGDWPC-NH2(Mpr&Cys bridge); L-Cysteinamide, N6-(aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl)-L-lysylglycylglycyl-L-α-aspartyl-L-tryptophyl-L-prolyl-, cyclic (1→7)-disulfide; deamino-Cys-hArg-Gly-Gly-Asp-Trp-Pro-Cys-NH2 (Disulfide bridge: Cys1-Cys8); Deamino-cysteinyl-L-homoarginyl-glycyl-glycyl-L-alpha-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide (1->8)-disulfide; Di-Gly3-Eptifibatide; (+Gly3)-Eptifibatide. Grade: ≥95%. CAS No. 868242-25-5. Molecular formula: C37H52N12O10S2. Mole weight: 889.02. | |
| Linear form, Eptifibatide impurity | Linear form, Eptifibatide impurity is an impurity of Eptifibatide, which is an antiplatelet drug of glycoprotein IIb/IIIa inhibitor. Synonyms: Mpr-(Homo-Arg)-Gly-Asp-Trp-Pro-Cys-NH2; Mpr-hArg-Gly-Asp-Trp-Pro-Cys-NH2. Molecular formula: C35H51N11O9S2. Mole weight: 833.98. | |
Our database is helping our users find suppliers everyday.
